Evidence map›Paper›PMID 29867514›Full record

ArticleFrontiers in pharmacology2018

Xiujie Liu, Yu Shi, Yinghui Hu, Ke Luo, Ying Guo, Weiwei Meng, Yulin Deng, Rongji Dai

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Review
  5. Article
  6. Article
  7. Review
  8. Wenxin Granules Influence the TGFCardiology research and practice · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xiujie LiuSchool of Life Science, Institute of Space Biology and Medical Engineering, Beijing Institute of Technology, Beijing, China.
Yu ShiSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
Yinghui HuSchool of Life Science, Beijing Institute of Technology, Beijing, China.
Ke LuoSchool of Life Science, Institute of Space Biology and Medical Engineering, Beijing Institute of Technology, Beijing, China.
Ying GuoSchool of Life Science, Institute of Space Biology and Medical Engineering, Beijing Institute of Technology, Beijing, China.
Weiwei MengSchool of Life Science, Beijing Institute of Technology, Beijing, China.
Yulin DengSchool of Life Science, Institute of Space Biology and Medical Engineering, Beijing Institute of Technology, Beijing, China.
Rongji DaiSchool of Life Science, Institute of Space Biology and Medical Engineering, Beijing Institute of Technology, Beijing, China.
Beijing Institute of Technology · CNInternational Space Science Institute - Beijing · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver fibrosis is a common pathological feature of many chronic liver diseases.

Indexed as

bioactive ingredientsBupleurum marginatum Wall.ex DCdifferential proteomicsliver fibrosisnetwork pharmacology

Identifiers

PMID29867514
PMCPMC5968385
OpenAlexW2803956627

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.